Johnson & Johnson: A Calculated Compliance

On January 8th, Johnson & Johnson secured a concession: reduced tariffs in exchange for lower drug prices within the country. The narrative presented is one of compromise. A more accurate description is one of compelled compliance. It is convenient to frame this as a win-win, but the reality is that Johnson & Johnson, like others, was left with little choice. To protest would have been to invite further disruption, a risk few are willing to take.








